InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Komjathy Andrew, Directeur Commercial. Director active across 1 company, notably Astria Therapeutics, Inc.. Aggregated, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €1k. Activity tracked since 19 November 2021. The latest transaction was disclosed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
100 shares@ US$6.695100.0% of flowCommon StockSEC:0001104659-21-143035
Ideal exit: 16 Aug 2022 (T+270)
100 shares@ US$6.69550.0% of flowCommon StockSEC:0001104659-21-143035:0
Ideal exit: 16 Aug 2022 (T+270)
2 of 2 declarations
About Komjathy Andrew
Komjathy Andrew is the Chief Commercial Officer at Astria Therapeutics, Inc. He oversees commercial operations and contributes to the company's growth strategy.
